Cullinan Therapeutics Inc
Cullinan Therapeutics Inc (CGEM) Option Chain
Read more
Tracking the CGEM option chain helps you see every strike and expiry on Cullinan Therapeutics Inc in one view, so you can quickly identify contracts that fit your thesis and your risk. It lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of CGEM options activity at a glance. Use our scanner to monitor the CGEM option chain in real time and filter for the trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For CGEM stock options, the chain shows call and put data side by side, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading it well means looking beyond the last price. Implied volatility by strike, volume to open interest ratios, and bid ask spreads all show where CGEM options are being actively traded, and where they are not.
Cullinan Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the developing of oncology and immuno-oncology therapies. Its pipeline includes CLN-978, CLN-619, Zipalertinib CLN-081/TAS6417, CLN-049, and CLN-617. The company was founded by Patrick A. Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA.
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 20.96 | 0 | 0 | 0.55 | 2.28 | 0.75 | 4.90 | 8.00 | -22.18 | — | 4.90 | 0.00 | 4.90 | 0 | 0 | 79.04 |
| 35.69 | 0 | 0 | 3.62 | 1.28 | — | 4.90 | 9.00 | -12.45 | — | 4.90 | 0.00 | 4.90 | 0 | 0 | 64.31 |
| 51.09 | 4 | 0 | 4.62 | 0.28 | — | 4.90 | 10.00 | -2.72 | — | 2.30 | 0.00 | 2.30 | 0 | 0 | 48.91 |
| 64.95 | 0 | 0 | 4.90 | 0.00 | — | 4.90 | 11.00 | +7.00 | 0.10 | 1.95 | 0.72 | 0.30 | 0 | 11 | 35.05 |
| 76.11 | 1 | 0 | 4.90 | 0.00 | — | 4.90 | 12.00 | +16.73 | — | 4.90 | 1.72 | 3.18 | 0 | 1 | 23.89 |
As of Nov 13, 2026
Prices move. This one stays.Lock in 5 years at a special price and save $2,243. Ending soon.See the Early Bird Black Friday deal →Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV Rank89.29% High
- Market cap (M$)667
- 52 weeks high-55.67%
- 52 weeks low29.63%
- Analyst recommendationStrong Buy
1.00 - Target price$34.75
238.04% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-10
- P/E—
- Future P/E—
- EPS (ttm)-3.30
- EPS growth next 5 years5.60%
As of Nov 13, 2026